GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) slow gastrointestinal transit, causing constipation in up to 1 in 10 patients
It also helps minimize muscle loss that can happen when youre eating on a GLP-1 medication
2 Department of Internal Medicine Unit, skdar University, NP Health Campus, mraniye, Istanbul, 34768, Trkiye Correspondence: Serap Cetiner, Email [email protected] Background: Obesity is a chronic metabolic disease associated with substantial cardiometabolic risk and long-term morbidity
L-carnitine supplementation at this critical juncture may enhance the body's capacity to oxidize released fatty acids, potentially improving: Fat oxidation efficiency: Enhanced mitochondrial function supports greater utilization of mobilized fat stores Energy levels: Improved fatty acid metabolism may reduce fatigue often associated with caloric restriction Muscle preservation: L-carnitine's role in protein metabolism may help maintain lean body mass during weight loss Metabolic flexibility: Better substrate utilization may improve metabolic health markers beyond weight alone Clinical Evidence and Emerging Research While large-scale studies specifically examining tirzepatide or semaglutide combined with L-carnitine remain limited, individual component research provides compelling support: A 2023 meta-analysis in Obesity Reviews demonstrated that L-carnitine supplementation contributed to significant additional weight loss compared to placebo, with an average reduction of 1.3 kg (2.86 lbs) over 12 weeks
Summary: B12 deficiency may be caused by malabsorption, poor dietary intake and/or pernicious anemia
)
